Who owns IONIS PHARMACEUTICALS INC?
- CUSIP Number: 462222af7
Tip: Access positions for across all investors
Analyze quarterly positions in Ionis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ionis Pharmaceuticals stock
Who bought or sold IONIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tenor Capital Management | 95M | $148M | 336% | Jun 2026 |
|
| Citadel Advisors | 87M | $135M | 49% | Jun 2026 |
|
| Ing Investment Management | 77M | $119M | -10% | Jun 2026 |
|
| Deerfield Management Company | 60M | $93M | 0% | Jun 2026 |
|
| DLD Asset Management | 60M | $94M | 9% | Jun 2026 |
|
| Ubs Global Asset Management Americas | 41M | $64M | 100% | Jun 2026 |
|
| LMR Partners | 40M | $62M | 7% | Jun 2026 |
|
| Balyasny Asset Management | 18M | $27M | -50% | Jun 2026 |
|
| Lazard Asset Management | 13M | $205k | -20% | Jun 2026 |
|
| State Street Corporation | 12M | $18M | -2% | Mar 2026 |
|
| Wellington Management Company | 12M | $18M | -17% | Jun 2026 |
|
| BlackRock | 11M | $18M | -40% | Jun 2026 |
|
| M&G | 7.3M | $11M | 0% | Jun 2026 |
|
| FMR | 7.0M | $11M | 0% | Jun 2026 |
|
| Lord, Abbett & Co | 6.6M | $10M | -7% | Jun 2026 |
|
| Colony | 5.2M | $8.1M | -2% | Jun 2026 |
|
| Advent Capital Management | 5.1M | $8.0M | 0% | Jun 2026 |
|
| Picton Mahoney Asset Management | 5.0M | $7.8M | 100% | Jun 2026 |
|
| State of Wisconsin Investment Board | 4.0M | $6.2M | 33% | Jun 2026 |
|
| Amundi | 3.5M | $5.4M | 0% | Jun 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 3.4M | $5.2M | -28% | Jun 2026 |
|
| Bnp Paribas Investment Partners | 3.1M | $4.9M | 0% | Jun 2026 |
|
| MacKay Shields | 2.4M | $3.8M | -77% | Jun 2026 |
|
| SSI Investment Management | 2.3M | $3.6M | 0% | Jun 2026 |
|
| Union Bancaire Privee, UBP SA | 1.9M | $2.6M | 0% | Jun 2026 |
|
| Bank Of Montreal | 1.3M | $1.9M | 100% | Mar 2026 |
|
| Calamos Advisors | 847k | $1.3M | -94% | Jun 2026 |
|
| Agf Management | 750k | $1.2M | 0% | Jun 2026 |
|
| Wells Fargo & Company | 635k | $989k | -87% | Jun 2026 |
|
| Jpmorgan Chase & Co | 553k | $873k | 100% | Jun 2026 |
|
| Barclays | 246k | $383k | -84% | Jun 2026 |
|
| Man Group | 180k | $280k | 0% | Jun 2026 |
|
| Calamos Wealth Management | 151k | $235k | 2% | Jun 2026 |
|
| UBS Group | 132k | $205k | 10% | Jun 2026 |
|
| Ares Systematic Credit | 100k | $156k | -80% | Jun 2026 |
|
| Royal Bank of Canada | 100k | $156k | -95% | Jun 2026 |
|
| Morgan Stanley | 94k | $142k | 0% | Mar 2026 |
|
| Branch Banking & Trust Company | 73k | $114k | 0% | Jun 2026 |
|
| Oppenheimer Asset Management | 72k | $112k | 100% | Jun 2026 |
|
| Nomura Holdings | 36k | $2.9M | -58% | Jun 2026 |
|
| Independent Financial Group | 32k | $50k | 100% | Jun 2026 |
|
| Stephens | 24k | $37k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 17k | $27k | -100% | Jun 2026 |
|
| Commonwealth Equity Services | 11k | $17k | 100% | Jun 2026 |
|
| Boussard & Gavaudan Investment Management | 1.0k | $1.5M | -92% | Mar 2026 |
|
| Oddo Bhf Asset Management Sas | 274.00 | $427k | -27% | Jun 2026 |
|
Who sold out of Ionis Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Aristeia Capital | Mar 2026 | 10M | $15M |
| Goldman Sachs Group | Mar 2026 | 2.5M | $3.7M |
| Bank of America Corporation | Mar 2026 | 980k | $1.5M |
| Leucadia National Corporation | Mar 2026 | 908k | $1.4M |
| Kohlberg Kravis Roberts & Co | Mar 2026 | 760k | $1.1M |
| Sei Investments | Mar 2026 | 105k | $158k |
| Loomis, Sayles and | Mar 2026 | 29k | $2.1M |
| Alpine Partners VI | Mar 2026 | 600.00 | $907k |